Thomson Medical Group
Market Cap
S$3.0b
Last Updated
2021/04/19 11:06 UTC
Data Sources
Company Financials
Executive Summary
Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore, Malaysia, the United Kingdom, China, the Middle East, and internationally. More Details
Risk Analysis
Snowflake Analysis
Adequate balance sheet with weak fundamentals.
Similar Companies
Share Price & News
How has Thomson Medical Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: A50 is more volatile than 75% of SG stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: A50's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of SG stocks.
Market Performance
7 Day Return
0.9%
A50
-0.7%
SG Healthcare
0.4%
SG Market
1 Year Return
90.0%
A50
42.3%
SG Healthcare
22.1%
SG Market
Return vs Industry: A50 exceeded the SG Healthcare industry which returned 42.3% over the past year.
Return vs Market: A50 exceeded the SG Market which returned 22.1% over the past year.
Shareholder returns
| A50 | Industry | Market | |
|---|---|---|---|
| 7 Day | 0.9% | -0.7% | 0.4% |
| 30 Day | -4.2% | -0.4% | 2.9% |
| 90 Day | 123.5% | 39.7% | 6.5% |
| 1 Year | 90.0%90.0% | 45.4%42.3% | 27.7%22.1% |
| 3 Year | n/a | -18.3%-24.6% | -0.3%-12.1% |
| 5 Year | n/a | -14.2%-23.7% | 21.2%-0.1% |
Long-Term Price Volatility Vs. Market
How volatile is Thomson Medical Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall St
We Think Thomson Medical Group (SGX:A50) Has A Fair Chunk Of Debt1 month ago | Simply Wall St
Eng Lim Just Bought A Sprinkling of Shares In Thomson Medical Group Limited (SGX:A50)2 months ago | Simply Wall St
Should You Take Comfort From Insider Transactions At Thomson Medical Group Limited (SGX:A50)?Valuation
Is Thomson Medical Group undervalued compared to its fair value and its price relative to the market?
6.14x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: A50 (SGD0.11) is trading above our estimate of fair value (SGD0)
Significantly Below Fair Value: A50 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: A50 is unprofitable, so we can't compare its PE Ratio to the SG Healthcare industry average.
PE vs Market: A50 is unprofitable, so we can't compare its PE Ratio to the SG market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate A50's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: A50 is overvalued based on its PB Ratio (6.1x) compared to the SG Healthcare industry average (1.7x).
Future Growth
How is Thomson Medical Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
24.3%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Thomson Medical Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Past Performance
How has Thomson Medical Group performed over the past 5 years?
-95.5%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: A50 is currently unprofitable.
Growing Profit Margin: A50 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: A50 is unprofitable, and losses have increased over the past 5 years at a rate of 95.5% per year.
Accelerating Growth: Unable to compare A50's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A50 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-11.6%).
Return on Equity
High ROE: A50 has a negative Return on Equity (-9.14%), as it is currently unprofitable.
Financial Health
How is Thomson Medical Group's financial position?
Financial Position Analysis
Short Term Liabilities: A50's short term assets (SGD241.6M) exceed its short term liabilities (SGD73.0M).
Long Term Liabilities: A50's short term assets (SGD241.6M) do not cover its long term liabilities (SGD627.8M).
Debt to Equity History and Analysis
Debt Level: A50's debt to equity ratio (107.5%) is considered high.
Reducing Debt: A50's debt to equity ratio has reduced from 202.2% to 107.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable A50 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: A50 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 32.6% per year.
Dividend
What is Thomson Medical Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate A50's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate A50's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if A50's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A50's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of A50's dividend in 3 years as they are not forecast to pay a notable one for the SG market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.1yrs
Average management tenure
CEO
Chiang Yin Wong (52 yo)
1.17yrs
Tenure
Dr. Chiang Yin Wong has been Executive Director and Group Chief Executive Officer of Thomson Medical Group Limited since February 1, 2020. Dr. Wong serves as an Independent Director of RHT Health Trust Man...
Leadership Team
Experienced Management: A50's management team is considered experienced (2.1 years average tenure).
Board Members
Experienced Board: A50's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: A50 insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Thomson Medical Group Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Thomson Medical Group Limited
- Ticker: A50
- Exchange: SGX
- Founded: 1979
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: S$2.961b
- Shares outstanding: 26.44b
- Website: https://www.thomsonmedicalgroup.com
Number of Employees
Location
- Thomson Medical Group Limited
- 101 Thomson Road, No. 20-04/05
- United Square
- Singapore
- 307591
- Singapore
Listings
Biography
Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore, Malaysia, the United Kingdom, China, the Middle East, and internationally. Th...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/04/19 11:06 |
| End of Day Share Price | 2021/04/19 00:00 |
| Earnings | 2020/12/31 |
| Annual Earnings | 2020/06/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.